Biotech · Private company
Immunis, Inc.
Track this companyFree. Adds Immunis, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- IMM01-STEMPhase 2 · Muscle AtrophyClinicalTrials.gov · fetched Nov 12, 2026
- IMM01-STEMPhase 2 · Muscle PerformanceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle WeaknessPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 19, 2024ClinicalTrials.gov NCT06600581 · fetched Nov 12, 2026
- Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.PHASE1_PHASE2 · COMPLETED · started Sep 13, 2022ClinicalTrials.gov NCT05211986 · fetched Nov 12, 2026